Prostate Cancer Clinical Trial

Multi-parametric Magnetic Resonance Imaging for Prostate Cancer Patients

Summary

This is a pilot study of implement multi-parametric MR imaging for organ delineation and tumor response assessment of prostate cancer patients being treated with radiation therapy. The study aims to generate intraprostatic lesions maps based on imaging, perform the treatment planning to compute the highest feasible simultaneous boosting dose to intraprostatic lesion and characterize longitudinal changes in imaging characteristics.

View Full Description

Full Description

The study aims to generate intraprostatic lesions maps based on imaging, perform the treatment planning to compute the highest feasible simultaneous boosting dose to intraprostatic lesion and characterize longitudinal changes in imaging characteristics.

View Eligibility Criteria

Eligibility Criteria

Inclusion Criteria:

Histologically confirmed prostate adenocarcinoma

Exclusion Criteria:

Patients with metal fragments or implanted devices such as pacemakers and aneurysm clips are not eligible for the study considering

Study is for people with:

Prostate Cancer

Estimated Enrollment:

9

Study ID:

NCT03180398

Recruitment Status:

Terminated

Sponsor:

Henry Ford Health System

Check Your Eligibility

Let’s see if you might be eligible for this study.

What is your age and gender ?

Submit

There is 1 Location for this study

See Locations Near You

Henry Ford Health System
Detroit Michigan, 48202, United States

How clear is this clinincal trial information?

Study is for people with:

Prostate Cancer

Estimated Enrollment:

9

Study ID:

NCT03180398

Recruitment Status:

Terminated

Sponsor:


Henry Ford Health System

How clear is this clinincal trial information?

×

Introducing, the Journey Bar

Use this bar to access information about the steps in your cancer journey.